Published: 2019-09-16   Views: 3
Author: kelvindbmr
Published in: Business

Pediatric Vaccine market accounted to USD 23.02 billion in 2016 growing at a CAGR of 10.4% during the forecast period of 2017 to 2024. The upcoming market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

Major Market Competitors: Pediatric Vaccine Market

Global Pediatric Vaccine market is dominated by Pfizer, Merck, Sanofi Pasteur, Crucell, Janssen, Bharat Biotech, Kaketsuken, Panacea Biotec, Baxter, ZydusCadila, Nuron, S K Chemicals, Dynavax Technologies, Serum Institute of India, Bharat Immunologicals and Biologicals, Lupin, Indian Immunologicals, Novartis, LG Life Sciences, Shenzhen Kangtai Biological Products, Sinovac Biotech, Bavarian Nordic, Bio Med, AstraZeneca, bioCSL, Valeant Pharmaceuticals, Takeda Pharmaceutical, and Mitsubishi Tanabe Pharma., and. among others.

Download PDF Sample report @

Pediatric Vaccine work as protective shield administered to a child in its paediatric age which is from 0 – 18 years of age. Vaccines are generally given in order to prevent children from diseases transferred through infections, seasonal variations and even through unhygienic areas.

Competitive Analysis: Pediatric Vaccine Market

The Pediatric Vaccine market is highly fragmented and is based on new product launches and clinical results of products. Hence the major players have used various strategies such as new product launches, clinical trials, market initiatives, high expense on research and development, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of Pediatric Vaccine market for global, Europe, North America, Asia Pacific, and South America.

Want Full Report? Enquire Here@   

Market Segmentation: Pediatric Vaccine Market

By product, the market for Pediatric Vaccine is segmented into pediatric vaccines, CNS drugs, pediatric hormones, allergy & respiratory drugs and anti-infective drugs.

By technology, the Pediatric Vaccine market is segmented into dendritic cells vaccines, live attenuated vaccines, synthetic vaccines, toxoid vaccines, inactivated vaccines, conjugate vaccines, recombinant vector vaccines and subunit vaccines. By disease, the Pediatric Vaccine market is segmented into Infectious disease, cancer and allergy.

By end user, the Pediatric Vaccine market is segmented into Pediatric, Adult.On the basis of geography, Pediatric Vaccine market report covers data points for 28 countries across multiple geographies such as North America & South America, Europe, Asia-Pacific, and Middle East & Africa. Some of the major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa, and Brazil among others. In 2017, North America is expected to dominate the market.

Major Market Drivers and Restraints:

  • Expanding government and privatespending
  • Rise in technological advancement
  • Growing awareness
  • Rising concern against vaccine-preventable diseases
  • Increasing investments

Speak to Author @

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market.


Data Bridge Market Research

Tel: +1-888-387-2818



Author Bio

This user has not submitted a user bio yet

Disqus Comments

Articles Search


Social Media

Forum Threads Search

Pages Search